fusionpharma.comThe Evolution of Radiopharmaceuticals - Fusion Pharma - Home

About Fusion Leadership Board Of Directors Advisory Board Contact Pipeline Expanded Access Policy Technology Technology Scientific Presentations Investors & Media Investors & Media News Releases Stock Information Corporate Governance Financial Information SEC Filings Events & Webcasts Investor Resources Careers Next-Generation Radiopharmaceuticals for precision medicine The Science Behind The Technology Targeted Alpha Therapeutics Fusion’s R&D team has developed ways to connect alpha emitting medical isotopes to molecules which selectively target biomarkers found on the surface of cancer cells.Targeted Alpha Therapeutics The Science Behind Targeted Alpha Therapies Alpha particles emitted from medical isotopes can be used to kill cancer cells by creating lethal, double stranded DNA breaks. Unlike most radiation therapies, alpha particles travel only one to three cell lengths, thereby creating the means to selectively kill tumor cells. At Fusion Pharma, we’re harnessing this potent and precise cell killing strategy to treat cancers via targeted alpha therapeutics.” Proprietary Fast-Clear ™ Technology The Fusion Advantage A Safer Approach to Targeted Radiopharmaceuticals Our team is dedicated to improving the lives of cancer patients and positively impacting patients’ families and the community. We created a proprietary linker to connect cancer-seeking molecules and alpha emitting medical isotopes. The Fast-Clear™ linker was specifically engineered to improve the safety of radiopharmaceuticals by helping the drug clear from normal, healthy tissues. The Fusion Advantage Our Manufacturing Expertise As we are a spin-out of a leading manufacturer and distributor of radiopharmaceuticals, the Centre for Probe Development and Commercialization (CPDC), we have experience building a robust supply chain. At Fusion, we develop targeted alpha therapeutics with the forethought of scale-up and reliable commercial production to meet the needs of the global market. Contact us JOIN THE TEAM info@fusionpharma.com Toll free +1 (888) 506-4215 Follow Our Progress Home About Pipeline Expanded Access Policy Technology Media Careers Contact CANADA 270 Longwood Road South Hamilton, ON, L8P 0A6 (289) 799-0891 UNITED STATES 2 International Place, Suite 2310 Boston, MA 02110 (617) 420-5698 © 2024 Fusion Pharma. All Rights Reserved About About Fusion Leadership Board Of Directors Advisory Board Contact Pipeline Expanded Access Policy Technology Technology Scientific Presentations Investors & Media Investors & Media News Releases Stock Information Corporate Governance Financial Information SEC Filings Events & Webcasts Investor Resources Careers x Learn more about investor resources Your Name (required) Your Email (required) Subject Your Message CLOSE Learn more about Fusion & our Investigational Trials Your Name (required) Your Email (required) Subject Your Message CLOSE Learn more about Fusion & Investigational Trials For general inquiries, please use the contact form or email. Name Email Who are you? Investor Healthcare Professional Patient Subject Message...